Literature DB >> 1741648

Elective and emergency hepatic resection. Determinants of operative mortality and morbidity.

A P Savage1, R A Malt.   

Abstract

To determine the reasons for improved mortality and morbidity rates after major hepatic resection, five variables were analyzed retrospectively in 300 patients operated on over a 27-year period: (1) the indication for surgery, (2) the surgical approach, (3) the urgency with which surgery was performed, (4) the nature of the surgical procedure, and (5) the experience of the surgeon. The operative mortality rate decreased from 19% between 1962 and 1979 to 9.7% between 1980 and 1988 (p less than 0.05). The operative mortality rates for patients undergoing resection for benign hepatic neoplasms was 3.4%; for metastatic tumors, 6.3%; for primary hepatic malignancies, 19%; and for trauma, 33%. Fifty-seven percent of operations before 1980 were performed through a thoracoabdominal exposure as compared with 19% after 1980. Overall a thoracoabdominal exposure of the liver was associated with a 20% mortality rate as compared with 8.6% for operations with abdominal exposure of the liver (p less than 0.02). Elective operations accounted for 65% of hepatic resections before 1980, as compared with 90% after 1980, and were associated with an 8.8% mortality rate as compared with 30.7% for urgent and emergency operations (p less than 0.001). Segmental and wedge resections were associated with a 5.3% mortality rate as compared with 14.7% for major hepatic resections (p less than 0.05), but this difference did not affect overall operative mortality rates because there was no change in the proportion of major hepatic resections after 1980. Surgical experience was not a determinant of operative mortality or morbidity rates in elective operations. Although there was no reduction in the complication rate after 1980, there was a reduction in postoperative stay from 26 days before 1980 to 16 days after 1980 (p less than 0.001). A reduction in the incidence of postoperative sepsis and a change in its management was associated with improved operative mortality rates.

Entities:  

Mesh:

Year:  1991        PMID: 1741648      PMCID: PMC1358493          DOI: 10.1097/00000658-199112000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  64 in total

1.  Hepatic lobectomy for metastatic cancer.

Authors:  A BRUNSCHWIG
Journal:  Cancer       Date:  1963-03       Impact factor: 6.860

2.  Results of resection of metastatic tumors of the liver.

Authors:  G F WOODINGTON; J M WAUGH
Journal:  Am J Surg       Date:  1963-01       Impact factor: 2.565

3.  Anesthetic management during total hepatic lobectomy.

Authors:  O SCHWEIZER; W S HOWLAND
Journal:  Surg Gynecol Obstet       Date:  1960-01

4.  Hepatic resection in 128 patients: a 24-year experience.

Authors:  M E Sesto; D P Vogt; R E Hermann
Journal:  Surgery       Date:  1987-11       Impact factor: 3.982

Review 5.  Surgery for hepatic neoplasms.

Authors:  R A Malt
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

6.  Liver resections in cirrhotic patients: a Western experience.

Authors:  H Bismuth; D Houssin; J Ornowski; F Meriggi
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

7.  Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis.

Authors:  G Gozzetti; A Mazziotti; A Cavallari; R Bellusci; L Bolondi; W Grigioni; R Bragaglia; G L Grazi; E De Raffele
Journal:  Surg Gynecol Obstet       Date:  1988-06

8.  Assessment of pattern and treatment of intrahepatic recurrence after resection of hepatocellular carcinoma.

Authors:  N Nagasue; H Yukaya; Y C Chang; A Yamanoi; H Kohno; T Hayashi; T Nakamura
Journal:  Surg Gynecol Obstet       Date:  1990-09

9.  Hepatoma in the noncirrhotic liver.

Authors:  S R Smalley; C G Moertel; J F Hilton; L H Weiland; H S Weiand; M A Adson; L J Melton; K Batts
Journal:  Cancer       Date:  1988-10-01       Impact factor: 6.860

10.  Surgical treatment of liver metastases from colorectal cancer.

Authors:  G Fegiz; M Bezzi; R De Angelis; B Provitera; G Ramacciato; R Maceratini; G Tucci; L Angelini
Journal:  Ital J Surg Sci       Date:  1985
View more
  26 in total

1.  Continuing evolution in the approach to severe liver trauma.

Authors:  D V Feliciano
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

Review 2.  Management of post-hepatectomy complications.

Authors:  Shan Jin; Quan Fu; Gerile Wuyun; Tu Wuyun
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

3.  Ligation of the Left Hepatic Duct and Proper Hepatic Artery Following a Traffic Accident Injury.

Authors:  Jiang Ou; Liu Yu; Cheng Nan-Sheng
Journal:  Indian J Surg       Date:  2017-03-01       Impact factor: 0.656

4.  Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases.

Authors:  Yoshihiro Mise; Reza J Mehran; Thomas A Aloia; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2014-06-20       Impact factor: 3.982

5.  Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial.

Authors:  Andrea Frilling; Gregor A Stavrou; Hans-Jörg Mischinger; Bernard de Hemptinne; Mogens Rokkjaer; Jürgen Klempnauer; Anders Thörne; Beat Gloor; Susanne Beckebaum; Mohamed F A Ghaffar; Christoph E Broelsch
Journal:  Langenbecks Arch Surg       Date:  2005-02-19       Impact factor: 3.445

6.  Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk.

Authors:  Alban Zarzavadjian Le Bian; Renato Costi; Vassilis Constantinides; Claude Smadja
Journal:  J Gastrointest Surg       Date:  2012-10-09       Impact factor: 3.452

7.  Population-based review of the outcomes following hepatic resection in a Canadian health region.

Authors:  Elijah Dixon; Oliver F Bathe; Andrew McKay; Isabelle You; Scot Dowden; David Sadler; Kelly W Burak; J Gregory McKinnon; Walter Miller; Francis R Sutherland
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

8.  Operative results in 143 patients with hepatocellular carcinoma.

Authors:  T Segawa; R Tsuchiya; J Furui; K Izawa; T Tsunoda; T Kanematsu
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

9.  A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use.

Authors:  N Yamanaka; E Okamoto; T Oriyama; J Fujimoto; K Furukawa; E Kawamura; T Tanaka; F Tomoda
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

10.  Pretreatment with enteral cholestyramine prevents suppression of the cellular immune system after partial hepatectomy.

Authors:  P A Van Leeuwen; M A Boermeester; A P Houdijk; S Meyer; M A Cuesta; R I Wesdorp; M L Rodrick; D W Wilmore
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.